drugset / Trial / NCT01591616

Pediatric Study to Access Pharmacokinetics and Safety of Oraqix Gel

NCT01591616

Phase 4 Completed 16 enrolled Dentsply International
NaSingle-groupOpen-labelOther

Summary

To establish Oraqix is safe when used on adolescent volunteers.

Timeline

Start
2010-04
Primary completion
2012-04
Completion
2012-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified
Subject prilocaine Small molecule

Indications